4//SEC Filing
ANSARI ABID 4
Accession 0001209191-20-030319
CIK 0001357874other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 7:17 AM ET
Size
11.3 KB
Accession
0001209191-20-030319
Insider Transaction Report
Form 4
ANSARI ABID
Chief Financial Officer
Transactions
- Exercise/Conversion
Employee Stock Options (Right to Buy)
2020-05-15−878→ 3,514 totalExercise: $1.18Exp: 2027-03-23→ Common Stock (878 underlying) - Exercise/Conversion
Common Stock
2020-05-15$1.18/sh+878$1,036→ 135,618 total - Exercise/Conversion
Employee Stock Options (Right to Buy)
2020-05-15−8,783→ 17,568 totalExercise: $1.20Exp: 2026-08-10→ Common Stock (8,783 underlying) - Exercise/Conversion
Common Stock
2020-05-15$1.20/sh+8,783$10,540→ 134,740 total
Footnotes (3)
- [F1]Includes 2,112 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 8, 2020.
- [F2]The option vested as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three month period over the 36 months following such date.
- [F3]The option vested as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three month period over the 36 months following such date.
Documents
Issuer
PRECISION BIOSCIENCES INC
CIK 0001357874
Entity typeother
Related Parties
1- filerCIK 0001770149
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 7:17 AM ET
- Size
- 11.3 KB